nano-diamino-tetraiodothyroacetic acid

nano-diamino-tetraiodothyroacetic acid
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2015-07-09 00:00:00
Sponsor NanoPharmaceuticals, LLC;1 Discovery Place;Rensselaer, New York, 12144
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM